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Abstract
Background: Systematic inflammatory syndrome causes death in many conditions. Inflammation and anti-inflammation parame-
ters variation monitoring were done by different clinical and lab methods, however, determining the progression of inflammation
is very important for on time interference, gaining best results, and cost controlling. In this condition, adrenal insufficiency’s vari-
ation causes water and electrolyte disorders, circulatory failure, and uncontrolled progression of inflammatory response, which
is very important. Routine serum total cortisol level monitoring for SIRS is not advised as yet, and corticosteroid was used blindly
according to hemodynamic condition and physician diagnosis.
Objectives: In this pilot study, the ability of first three days monitoring serum total cortisol level in SIRS of burned ICU traumatic
patients was studied for outcoming improvement.
Methods: A total of 60 patients, 15 - 70 years old, < 80% burn, with systemic inflammatory response syndrome, during first three
days of admission in the ICU, that weren’t included in the exclusion criteria (patients with history of clinical adrenal insufficiency
or corton usage, or recent drug history of etomidate or ketoconazole), were divided randomly between two groups with 30 patients.
The first group considered under the routine clinical treatment and in the second group, besides the routine methods cortisol daily
measurement at 8 o’clock, was done during three days to find the cortisol level under 15 ug/dL, and replacement therapy with 50 mg
hydrocortisone IV, four times a day.
Results: None of the patients had a cortisol drop during their first three days. Among patients with cortisol more than normal, 20%
(6 patients) died.
Conclusions: Despite the fact that total serum cortisol drop during systemic inflammatory response syndrome may happen, it is
not prevalent, however, it is wise to consider it as an effective parameter on monitoring of treatment measures.
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1. Background
In 1992, the American College of Chest Physicians and
the American Health Care Association introduced systemic
inflammatory response syndrome (SIRS) as definitions of
systemic inflammatory response syndrome, sepsis, shock,
and multiple organ failure. The purpose of the definition
of SIRS is determination of the clinical response to the in-
juries due to the infectious or noninfectious agent. Sys-
temic inflammatory response syndrome (SIRS) is charac-
terized by the following factors: the patients were involved
with body temperature more than 38°C or less than 36°C,
the heart rate more than 90 bpm, respiratory rate more
than 20 times per minute, pressure of carbon dioxide gas
less than 32 mmHg, and the white blood cell count more
than 12000 or less than 4000. The SIRS is non-specific and
can be due to trauma, inflammation, ischemia, infection,
or multiple injuries (1, 2).
The SIRS has the same pathophysiological features
with inflammatory cascade, however, it has minor differ-
ences at the onset of cascade. Many researchers consider
this syndrome as a native defense mechanism. The in-
flammation is the body’s response to non-specific injuries
caused by chemical stimuli, trauma, or infection. Inflam-
matory cascade is a complex process that includes hu-
moral and cellular responses, complexes, and cytokine cas-
cades. Bone et al., summarized the best relationship be-
tween the complex interactions and SIRS in a three-step
process. At the first stage, the cytokines are produced by
the immune cells in place after an injury; the local produc-
tion of cytokines causes a cellular inflammatory response
and induces improvement of ulcer healing by the retic-
uloendothelial system; this process is essential for non-
specific defense. Local inflammation in the skin and sub-
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cutaneous soft tissue is characterized by classic redness,
swelling, pain, warmth, and loss of function (3).
At the second stage, the low quantities of local cy-
tokines are released into the bloodstream and improves lo-
cal responses. This stimulates the growth factors and accu-
mulates macrophages and platelets. This response is typi-
cally controlled by the reduction of pre-inflammatory me-
diators and the release of intrinsic antagonists; the goal is
to maintain homostasis. At this stage, some symptoms in-
cluding mild body temperature may appear.
In the end stage, if homeostasis is not maintained and
the inflammatory stimuli exist in the systemic circulation
of the body, a large systemic reaction occurs. The distribu-
tion of cytokines leads to activation of multiple humoral
cascades and activation of the endothelial reticulum sys-
tem subsequently cause loss of circulatory integrity, sub-
sequently leading to organ dysfunction (2, 3).
The role of glucocorticoids in the pathophysiology of
acute illnesses was interested for researchers due to the
fact that adrenal glands are essential for survival under
physiological stress conditions (4, 5); the clinical studies of
cortisone demonstrated potential role of corticosteroids
in the treatment of infections (6, 7).
The hypothalamus secretes the corticotropin releasing
hormone (CRH) under the threat of hemostasis, which re-
sults in the release of adrenocorticotropin (ACTH) from the
anterior pituitary and induces cortisol secretion from the
adrenal glands.
The normal level of cortisol is between five to 24µg/dL,
which is strongly dependent on hourly specimen taking
overnight (7). The hypothalamus-adrenal axis (HPA) acti-
vates under physiological stress (such as major surgery,
pressure drop, severe infection) and its daily changes dis-
appear (8, 9), subsequently, levels of cortisol up to 40 to
50µg/dL (2, 8, 10-13), as well as metabolism and function of
cortisol may change due to acute illness and decrease cor-
tisol destruction (due to inhibition of expression and func-
tion of cortisol metabolizing enzymes); in addition, corti-
cotropin levels are suppressed due to a high level of cor-
tisol (13). Renal dysfunction may increase the half-life of
cortisol in circulation. The plasma concentration of both
cortisol bounding globulin (CBG) and cortisol bounding
albumin reduced, subsequently free cortisol (physiologi-
cally active form of the hormone) concentration increase
(2, 14, 15).
The cytokines, due to inflammatory may increase the
affinity of glucocorticoid receptors to cortisol, and in-
crease the concentration of peripheral precursors of cor-
tisol (2, 16, 17).
The defects of HPA axis in head injuries, weaknesses of
central nervous system, pituitary infarction, adrenal hem-
orrhage, infections, malignancies, and previous use of glu-
cocorticoids can occur (2, 18-23).
Several studies have found that both low and high lev-
els of serum cortisol increase mortality (24-26). In sick
patients, the level of cortisol bounding globulin (CBG)
reduces the protein-bounding cortisol and increases the
free cortisol level, therefore, there is a shift from an in-
active form (protein-bounding cortisol) to physiologically
active form (free cortisol) and it suggests that the standard
method of measuring plasma cortisol, which measures the
total plasma cortisol concentration, estimates the activity
of the axis of HPA less than actual, and the free cortisol mea-
surement in the evaluation of the HPA axis is more accurate
(27).
Systemic inflammatory response syndrome (SIRS) oc-
curs in many conditions and leads to mortality such as sep-
sis. Sepsis alone causes more than a quarter of the mor-
talities and evaluation of changes in various inflamma-
tory factors have been carried out by different clinical and
laboratory methods. However, in spite of the availability,
specificity and the effectiveness of these methods such as,
the determination of the changes leading to the develop-
ment of inflammation in a short time for timely interven-
tion, achieving the best results, and controlling costs are
very important. The Adrenal insufficiency is important for
changes in water and electrolyte and circulatory failure
due to vascular tone and also for uncontrolled progression
of inflammatory responses. The measurements of cortisol
have not been evaluated for SIRS.
Many physicians prescribe corticosteroids for SIRS pa-
tients; the importance and outcome of this issue has not
been discussed so far.
2. Objectives
The aim of the study was evaluation of secretary corti-
sol levels from adrenal response to burn trauma. If cortisol
is reduced, treatment and care will be increased, as well as
interventions for acquired adrenal insufficiency.
3. Methods
A total of 60 patients, 15 - 70 years old, < 80% burn,
with systemic inflammatory response syndrome, during
the first three days of admission in the ICU, that weren’t
included in the exclusion criteria (patients with history
of clinical adrenal insufficiency or corton usage, or recent
drug history of etomidate or ketoconazole), divided ran-
domly between two groups with 30 patients. The first
group was considered under the routine clinical treatment
and the second group, besides the routine methods corti-
sol daily measurement at 8 o’clock, was done during three
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days to find the cortisol level under 15 ug/dL, and replace-
ment therapy with 50 mg Hydrocortisone IV, four times per
day.
The results of quantitative variables were expressed
as mean and standard deviation (mean ± SD) and were
expressed as percentage for the class qualitative vari-
ables. Comparison between quantitative variables was
performed by t-test or if there was an abnormal distribu-
tion by Mann-Whitney test. A comparison between quali-
tative variables was also performed using Chi-square test
or Fisher’s exact test. Correlation between quantitative
variables was investigated using Pearson correlation coef-
ficient and Spearman rank correlation tests. Data were an-
alyzed by SPSS software version 25 for statistical analysis.
The significance level was less than 0.05.
4. Results
Table 1 shows the demographic data of the patients in
the study. Of the 30 patients evaluated, six patients were
female and 24 patients were male. Six patients died and 24
of them lived in the ICU ward of Shahid Motahari Hospital.
The mean and standard deviations of variables such as
body temperature, leukocyte count, age, heart rate, respi-
ratory rate, carbon dioxide, non-survivor time in the dead
group, duration of survival, and burn percentage were
shown in Table 2.






a Values are expressed as No. (%).
Table 2. Demographic Data of the Variables
Variables Max Min Valuea
Age 67 16 32 ± 14.1
Body temperature 39.2 36.5 37.3 ± 0.6
Leukocyte count 39 3 15.4 ± 10.5
Heart rate 160 80 118.5 ± 19.8
Respiratory rate 28 12 21 ± 4.4
Carbon dioxide 55 27 36.6 ± 7.8
Non-survivor time 43 4 15.8 ± 12
Burn percentage 75 5 41.8 ± 17.2
a Values are expressed as mean ± SD.
Table 3 shows standard deviation and P value in vari-
ables between two groups (non-survivor -survivor). The
data were analyzed using non-parametric Mann-Whitney
test. The results were demonstrated that variables includ-
ing survival time, body temperature, and burn percentage
were significantly different among the studied groups.
Friedman test was used to calculate the difference
change in concentration of cortisol; the cortisol daily mea-
surement at 8 o’clock was done during 3 days. According
to the results, the mean concentration of cortisol in the
non-survivor group was higher than the survivor group.
The concentration of cortisol decreased during the study
in both groups. Finally, change in concentration of corti-
sol was not significant in the study (P value = 0.58) (Table
4).
Systems that estimate the risk of hospital mortality
based on the severity of disease lesions, particularly in the
field of intensive care, have become increasingly popular
over the past 20 years. The first introduced acute physi-
ology and acronym assessment (APACHE) in 1981 and the
simplified acute physiology score (SAPS) in 1988. Further
Table 3. The Difference in Mean of Variables in the Studied Groups
Group Valuea P Value
Leukocyte count 0.16
Survivor 13.8 ± 9.6
Non-survivor 21.6 ± 12.4
Heart rate 0.054
Survivor 115 ± 17.8
Non-survivor 132.5 ± 23
Respiratory rate 0.23
Survivor 21.6 ± 3.9
Non-survivor 18.6 ± 6.1
Carbon dioxide 0.9
Survivor 36.6 ± 7.8
Non-survivor 38.8 ± 8.4
Non-survivor time 0.03
Survivor 30.2 ± 3.8
Non-survivor 16.5 ± 12.5
Burn percentage 0.05
Survivor 39 ± 14.8
Non-survivor 52.8 ± 23.2
Body temperature 0.008
Survivor 37.5 ± 0.6
Non-survivor 36.8 ± 0.3
a Values are expressed as mean ± SD.
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Table 4. The Change in Concentration of Cortisol
Group Valuea
Day 1
Survivor 60.7 ± 21.1
Non-survivor 66.7 ± 18.3
Day 2
Survivor 53.8 ± 17.7
Non-survivor 59 ± 17.6
Day 3
Survivor 46.4 ± 16.8
Non-survivor 50.6 ± 19.4
a Values are expressed as mean ± SD.
Table 5. Changes in Apache 3 Score
Group Valuea P Value
Apache score at the beginning of followup 0.001
Survivor 34.4 ± 9.8
Non-survivor 68.8 ± 25.1
Apache score at the end of followup 0.001
Survivor 27 ± 10
Non-survivor 74 ± 26.8
a Values are expressed as mean ± SD.
research led to improved versions of APACHE II (28) was de-
veloped in 1985 and SAPS II (29) in 1993. The APACHE III ver-
sion (29) is now generally used and its version IV is being
reviewed and developed by the HIS system of hospitals. In
addition, the sequential organ failure assessment (SOFA)
score is used to follow up a person’s condition through-
out settling in an ICU to find out the level of a person’s or-
gan function or failure. Both SOFA and APACHE scores were
recorded as clinical factors (30); the results demonstrated
an increase in SOFA score for the non-survivor group than
that of survivors. However, this difference in SOFA score
was not statistical significance in the study groups (P value
= 0.6). Changes in Apache 3 score were recorded at the
beginning and the end of follow up of patients (Tables
5 and 6). According to the results of the study, the dif-
ference in mean Apache score between both survivor and
non-survivor groups was statistical significance.
5. Discussion
In the study, most patients (80%) were men who were
expected to be more involved with addiction and haz-
ardous occupations. The average age of the patients was
32 years. Due to the relative young age of the patients, the
Table 6. Changes in SOFA Score
Group Mean of SOFA Score± SD
Day 1
Survivor 3.1 ± 1.5
Non-survivor 5.6 ± 2.6
Day 2
Survivor 3.2 ± 1.5
Non-survivor 5.6 ± 2.3
Day 3
Survivor 3.2 ± 1.6
Non-survivor 6.4 ± 1.6
Day 4
Survivor 3.2 ± 1.4
Non-survivor 6 ± 1.8
Day 5
Survivor 3.2 ± 1.5
Non-survivor 5.6 ± 2.3
Day 6
Survivor 2.6 ± 1.2
Non-survivor 5.8 ± 2.1
Day 7
Survivor 2.2 ± 1.2
Non-survivor 5 ± 1.5
role of education at school is important to controlling and
preventing.
The average respiratory rate in the survivor group (21.6)
was higher than non-survivor group (18.6), although it was
not statistically significant. The average respiratory rate is
20, with a high average of carbon dioxide (about 36), de-
spite the average percentage of burns (40%), it indicates
high levels of opioid usage in non-survivor group. There-
fore, the opioid usage may cause reductions in average res-
piratory rate in the non-survivor group and can have an un-
favorable effect on the outcome of the treatment.
The average heart rate was higher in the non-survivor
group (130) than survivor group (115), although it is not sta-
tistically significant, it indicates that the general status of
the non-survivor patients was worse. Due to the fact that
the mean percentage of burns in the survivor group (39%)
was lower than non-survivor group (52.8%), it was statis-
tically significant. However, in order to be more similar
to the statistical population, the burn percentage was not
over 80%. Therefore, this high percentage of burns and
stress caused by it, in non-survivor group, can be due to the
worse general status of them.
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The non-survivor group died after the second week, at
this time, the main cause of deathis resistant infections;
therefore, control of long-term resistant infections is very
important in the field of epidemiological. Strategies such
as control of personnel and equipments, limitation of con-
tact in nonprofessional training teams with infections pa-
tients, hand hygiene, minimizing the need for intravenous
nutrition, using of minimal sedation, and using of new an-
tibiotics is very important for controlling mortality.
The mean concentration of cortisol in the non-survivor
group was higher than the survivor group. The concentra-
tion of cortisol decreased during the study in both groups.
Finally, change in concentration of cortisol was not signif-
icant in the study (P value = 0.58). Animal studies that
have shown fluid therapy for burn patients depending on
the percentage of burns causes increase excretion of corti-
sol; however, the expression of cortisol synthesizing genes
does not increase (31). In our study, urinary cortisol was not
measured, however, changes in serum cortisol levels did
not reach the therapeutic range after three days.
Aissa et al. reported a case report of a 60-year-old pa-
tient with only 35% burns, in spite of controlling regenera-
tion, the patient was rapidly treated with resistance-shock
(32).
This critical drop in cortisol levels was not show in the
study, and all patients survived for more than a week. The
disruptive factor was that the center of reference was in
fact a referral hospital, which may be that the patient suf-
fered a severe cortisol decline in the previous stage and
died with a shock, therefore, it was not included in the as-
sessment.
Fuchs et al. evaluated 20 corticotropin-releasing hor-
mone tests in referral burned patients after one day. They
demonstrated cortisol secretion in 7 of 20 patients and
showed developed adrenal insufficiency in 4 patients. This
indicated the abbreviated burn severity index correlate
with the risk of developing adrenal insufficiency (P =
0.008). In addition, they reported a higher mortality rate
in adrenal insufficiency patients; however, this observa-
tion was not significant (P = 0.11). They recommend that
further studies should be performed to benefit from corti-
sol replacement (33).
Endocrinological imbalance has been investigated by
significant amount of studies specifically on changes in
cortisol levels in burned traumatic patients (2, 34, 35).
These studies indicated an increase in cortisol level come-
back to severe trauma (36-38).
The mean Apache score of survivor group was lower
than non-survivor group, which is statistically significant
and due to a slight decrease. This score indicates failure to
improve the general condition of non- survivor patients.
SOFA score were recorded as a clinical factor for organ
function or failure; the results demonstrated an increase
in SOFA score for the non-survivor group than that of sur-
vivors, which, although not statistically significant, it indi-
cates a worsening of the general status of the non- survivor
patients at the time of arrival to hospital.
5.1. Conclusions
None of the patients had a cortisol drop during the first
three days. Among patients with a cortisol more than nor-
mal, 20% (six patients) died. Despite, total serum cortisol
drop during systemic inflammatory response syndrome
may happen, it is not prevalent, however, it is wise to con-
sider it as an effective parameter on monitoring of treat-
ment measures. Burned patients will involve sepsis dur-
ing the course of treatment; therefore, they will involve
adrenal insufficiency with higher rate despite treatment.
Subsequently, the proper titers of cortisol should be inves-
tigated.
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